
It brings together evidence planning, product strategy, and scientific communications into a single integrated ecosystem.
Instead of managing evidence across disconnected spreadsheets, slides, and repositories, ATLAS provides a living strategic roadmap that aligns cross-functional teams around the evidence needed to support product differentiation and patient access.
New AI Capabilities
Maia helps teams:
Identify evidence gaps
Draft value messages
Summarize scientific publications
Answer internal questions about the evidence package
Suggest new evidence generation activities
Internal functions (e.g., Clinical Development, HEOR, Medical Affairs, and Market Access frequently develop separate evidence plans.
This approach can lead to:
duplicate research
missed evidence gaps
misalignment between teams
inefficient resource allocation
ATLAS enables teams to plan evidence strategically from the beginning, aligning studies, communications, and strategy around a shared roadmap.
Built by experts with decades of experience in value & access, HEOR, and pharmaceutical strategy.
ATLAS has been shaped through collaboration with pharmaceutical companies across multiple therapeutic areas.
Arysana is ISO certified, demonstrating our commitment to operational excellence, data protection, and risk management.
Our processes meet internationally recognized standards for quality, security, and continuous improvement.
What This Means for You?
Gavin
Elizabeth
Tyler





